504 Plans and HCM

By admin | October 27, 2022

We understand how challenging it can be to manage life with HCM, and we want to lend a hand.As such, this is the first in a series of short articles to help to get you started concerningissues such as a 504 plan for your child’s school. Other examples are, what qualifies you forSocial Security Disability…

Read More

Cardiac implantable device infections

By admin | June 6, 2022

The HCMA participated in an American Heart Association summit of more than 40 health care professionals to bridge gaps in awareness, detection, and appropriate treatment of cardiac implantable electronic device (CIED) infections.

Read More

CYTOKINETICS AFICAMTEN RESEARCH

By admin | May 27, 2022

REDWOOD-HCM OLE REDWOOD-HCM OLE: First Long-Term Data from Open Label Extension Cytokinetics’ also announced positive data relating to aficamten from REDWOOD-HCM OLE (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM Open Label Extension) and the results from two additional analyses of omecamtiv mecarbil from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), all presented in Late-Breaking Science Sessions at Heart Failure 2022, an International Congress of the European Society of Cardiology.…

Read More